Group 1 - Company announced a share repurchase plan to be approved at the board meeting on December 11, 2025 [1] - The top ten unrestricted shareholders hold approximately 119 million shares, accounting for 71.29% of total shares [1] - The largest shareholder, Lin Junhua, holds about 78.37 million shares, representing 47.15% [1] Group 2 - For the year 2024, the company's revenue composition shows that specialized equipment manufacturing accounts for 98.7% of total revenue, while other businesses account for 1.3% [2] - The current market capitalization of the company is 2.5 billion yuan [3]

证券代码：688310 证券简称：迈得医疗 公告编号：2025-053 一、公司前十大股东持股情况 | 7 | 张鹏 | 1,189,804 | 0.72 | | --- | --- | --- | --- | | 8 | 涂筱莲 | 1,029,682 | 0.62 | | 9 | 张海 | 1,018,202 | 0.61 | | 10 | 中国建设银行股份有限公司－交银施罗德稳 | 963,771 | 0.58 | | | 健配置混合型证券投资基金 | | | 二、公司前十大无限售条件股东持股情况 | 序号 | 持有人名称 | 持股数量 | 占总股本比例 | | --- | --- | --- | --- | | | | （股） | （%） | | 1 | 林军华 | 78,372,560 | 47.15 | | 2 | 陈万顺 | 24,754,800 | 14.89 | | 3 | 台州赛纳投资咨询合伙企业（有限合伙） | 5,727,120 | 3.45 | | 4 | 迈得医疗工业设备股份有限公司回购专用证 | 2,592,575 | 1.56 | | | 券账户 | | | | 5 | 申万菱 ...

Core Viewpoint - The company, Maide Medical, has announced a share repurchase plan approved by its board of directors during a meeting held on December 11, 2025, indicating a strategic move to enhance shareholder value [2]. Group 1 - The board of directors approved the proposal for share repurchase through centralized bidding [2]. - The details of the share repurchase plan were disclosed in a public announcement on December 13, 2025, on the Shanghai Stock Exchange [2]. - The announcement includes the resolution from the eighth meeting of the fifth board of directors [2].

Group 1 - The company is currently operating normally and has confirmed its business status in response to investor inquiries [1] - The commercialization of the company's contact lens business is still in its early stages, and its revenue has not yet significantly impacted overall company performance [1] - The company is in the process of applying for registration certificates for daily disposable soft hydrophilic contact lenses [1]

有投资者在投资者互动平台向 迈得医疗公司提问：1.贵公司近期下跌幅度远高于行业平均水平，是否经 营正常？2.隐形眼镜，上市后销售情况如何？3.日抛取证，预计什么时候有结论？ 迈得医疗回复称，公 司目前处于正常经营状态。公司隐形眼镜业务商业化尚处于起步阶段，收入对公司业绩尚未产生重大影 响。且公司目前正在申请佩戴周期为日抛的软性亲水接触镜注册证照。 ...

Group 1: Company Announcements - Yongding Co., Ltd. does not directly manufacture controllable nuclear fusion devices but provides materials for the winding magnets of such devices [1] - Aerospace Power's main business does not involve commercial aerospace, nor does it have any commercial aerospace-related assets for external investment [1] - Zhibang Home intends to repurchase company shares worth between 80 million to 110 million yuan [3] Group 2: Investment Projects - Jiangsu Longsheng Weirui plans to invest approximately 350 million yuan to establish an intelligent robot innovation center [1] - Hainan Development's Zhuhai Sanxin plans to invest in the second phase of its production base project in Zhuhai [2] - New Fengming intends to invest 280 million USD to build a 360,000 tons/year functional fiber project in Egypt [2] Group 3: Contracts and Bids - Dayu Irrigation has pre-won the construction project for high-standard farmland in Inner Mongolia's Chifeng City for 2025 [1] - Dayu Irrigation has also pre-won the construction project for high-standard farmland in Inner Mongolia's Tongliao City for 2025 [2] - *ST Zhisheng has won the bid for the smart city governance (Phase IV) project [1] Group 4: Equity Transactions - Rongzi Technology plans to acquire 54.9688% of Guizhou Xinren's shares for 342 million yuan and will also increase its capital [3] - Tiankang Biological intends to purchase 51% equity of Qiangdu Livestock [2] - Binhai Energy plans to acquire 51% equity of Xingtai New Energy [3] Group 5: Share Buybacks and Holdings - Maide Medical plans to spend between 20 million to 40 million yuan to repurchase shares [3] - Tianli Technology's Qian Yongyao intends to reduce his holdings by no more than 3% [3] - Haichuan Intelligent's Wu Guifang and Zheng Xuefen plan to collectively reduce their holdings by no more than 5.98% [3] Group 6: Fundraising Activities - Tianshun Wind Power plans to raise no more than 1.95 billion yuan through a private placement [3] - Leisai Intelligent plans to raise no more than 1.144 billion yuan through a private placement [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688310 证券简称：迈得医疗 公告编号：2025-051 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份金额：不低于人民币2,000万元（含），不超过人民币4,000万元（含） ● 回购股份资金来源：公司首次公开发行股票超募资金或自有资金 ● 回购股份用途：用于减少公司注册资本 ● 回购股份价格：不超过人民币24元/股（含）。该价格不高于公司董事会通过回购股份决议前30个交 易日公司股票交易均价的150% ● 回购股份方式：集中竞价交易方式 ● 回购股份期限：自公司股东会审议通过本次回购股份方案之日起12个月内 ● 相关股东是否存在减持计划：公司董事、高级管理人员、控股股东、实际控制人及其一致行动人、回 购提议人、持股5%以上股东在未来3个月、未来6个月暂无减持公司股份的计划。若上述人员未来拟实 施股份减持计划，公司将按相关规定及时履行信息披露义务 本次回购股份方案尚需提交公司股东会审议。公司将于2025年12月30日召开2025 ...

北京商报讯（记者 丁宁）12月12日晚间，迈得医疗（688310）发布公告称，基于对公司未来发展的信 心和对公司价值的认可，为有效维护广大股东利益，增强投资者信心，在综合考虑公司财务状况以及未 来盈利能力的情况下，公司拟进行本次回购股份，用于减少公司注册资本。回购股份金额不低于2000万 元（含），不超过4000万元（含）。 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - The company plans to repurchase shares using funds from its IPO surplus or its own funds, with the repurchased shares intended to reduce the registered capital [1] - The repurchase period is set for 12 months from the date the shareholders' meeting approves the repurchase plan [1] - The estimated number of shares to be repurchased ranges from approximately 833,300 to 1,666,700, representing about 0.50% to 1.00% of the company's total share capital [1] Group 2 - As of September 30, 2025, the company's total assets are 1.198 billion yuan, with net assets attributable to shareholders of 806 million yuan and current assets of 729 million yuan [1] - The estimated maximum repurchase funds will account for approximately 3.34%, 4.96%, and 5.49% of the respective financial data [1] - The company's debt-to-asset ratio stands at 29.86%, indicating that the repurchase will not significantly impact its debt repayment capability [1] Group 3 - The main business of the company is the research, production, sales, and service of medical consumables and intelligent equipment, integrating technology in medical device processes, automation, and software [1] - The company's primary products include safety infusion devices and blood purification equipment [1] - In the first three quarters of 2025, the company achieved total operating revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.8367 million yuan, a year-on-year increase of 15.82% [1]